Harsimar Kaur

1.1k total citations
29 papers, 548 citations indexed

About

Harsimar Kaur is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Harsimar Kaur has authored 29 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Harsimar Kaur's work include Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Harsimar Kaur is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Harsimar Kaur collaborates with scholars based in United States, India and Serbia. Harsimar Kaur's co-authors include Tamara L. Lotan, Edward M. Schaeffer, Emmanuel S. Antonarakis, Sanjana Murali, Daniela C. Salles, Scott A. Tomlins, William B. Isaacs, Angelo M. De Marzo, Jiayun Lu and Corinne E. Joshu and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer.

In The Last Decade

Harsimar Kaur

28 papers receiving 541 citations

Peers

Harsimar Kaur
Joe Hasei Japan
Woo Ram Kim South Korea
George M. Yousef United States
Harsimar Kaur
Citations per year, relative to Harsimar Kaur Harsimar Kaur (= 1×) peers Victor Kwan Min Lee

Countries citing papers authored by Harsimar Kaur

Since Specialization
Citations

This map shows the geographic impact of Harsimar Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harsimar Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harsimar Kaur more than expected).

Fields of papers citing papers by Harsimar Kaur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harsimar Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harsimar Kaur. The network helps show where Harsimar Kaur may publish in the future.

Co-authorship network of co-authors of Harsimar Kaur

This figure shows the co-authorship network connecting the top 25 collaborators of Harsimar Kaur. A scholar is included among the top collaborators of Harsimar Kaur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harsimar Kaur. Harsimar Kaur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaur, Harsimar, Lawrence Hsu Lin, David L. Kolin, et al.. (2025). Primary Endometrial Gastric (Gastrointestinal)-type Mucinous Adenocarcinoma. The American Journal of Surgical Pathology. 49(6). 564–577. 3 indexed citations
2.
Sharma, S.D., et al.. (2024). Enhancing mental health care with AI: a review discussing biases, methodologies, and clinician preferences. International Journal of Research in Medical Sciences. 12(11). 4371–4377. 1 indexed citations
4.
Vidotto, Thiago, Eddie L. Imada, Farzana A. Faisal, et al.. (2023). Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer. JCI Insight. 8(3). 3 indexed citations
5.
Mendes, Adrianna A., Jiayun Lu, Harsimar Kaur, et al.. (2022). Association of B7‐H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer. Cancer. 128(12). 2269–2280. 18 indexed citations
6.
Kaur, Harsimar, Daniela C. Salles, Radhika A. Patel, et al.. (2022). Clonal relationships of adjacent Gleason pattern 3 and Gleason pattern 5 lesions in Gleason Scores 3+5=8 and 5+3=8. Human Pathology. 130. 18–24. 1 indexed citations
8.
Lotan, Tamara L., Harsimar Kaur, Daniela C. Salles, et al.. (2021). Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer. Modern Pathology. 34(6). 1185–1193. 67 indexed citations
9.
Kaur, Harsimar, Thiago Vidotto, Adrianna A. Mendes, et al.. (2021). Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer. Cancer Immunology Immunotherapy. 71(4). 943–951. 14 indexed citations
10.
Faisal, Farzana A., Sanjana Murali, Harsimar Kaur, et al.. (2020). CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer. Clinical Cancer Research. 26(11). 2595–2602. 23 indexed citations
11.
Kaur, Harsimar, Daniela C. Salles, Sanjana Murali, et al.. (2020). Genomic and Clinicopathologic Characterization of ATM -deficient Prostate Cancer. Clinical Cancer Research. 26(18). 4869–4881. 25 indexed citations
12.
Kaur, Harsimar, et al.. (2020). Primary ureteral lymphoma presenting as bilateral obstructive uropathy. Urology Case Reports. 33. 101296–101296. 1 indexed citations
13.
Jarrett, Junko, Brandon Ellis, Harsimar Kaur, et al.. (2020). Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays. Journal of Clinical Virology. 127. 104384–104384. 89 indexed citations
14.
Faisal, Farzana A., Harsimar Kaur, Jeffrey J. Tosoian, et al.. (2019). SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy. Prostate Cancer and Prostatic Diseases. 22(4). 552–559. 9 indexed citations
15.
Kaur, Harsimar, Jiayun Lu, Liana B. Guedes, et al.. (2019). TP53 missense mutation is associated with increased tumor-infiltrating T cells in primary prostate cancer. Human Pathology. 87. 95–102. 34 indexed citations
16.
Asrani, Kaushal, Sanjana Murali, Brandon Lam, et al.. (2019). mTORC1 feedback to AKT modulates lysosomal biogenesis through MiT/TFE regulation. Journal of Clinical Investigation. 129(12). 5584–5599. 31 indexed citations
17.
Kaur, Harsimar, Liana B. Guedes, Jiayun Lu, et al.. (2018). Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer. Modern Pathology. 31(10). 1539–1552. 68 indexed citations
18.
Asrani, Kaushal, Anil K. Sood, Alba Torres, et al.. (2017). mTORC1 loss impairs epidermal adhesion via TGF-β/Rho kinase activation. Journal of Clinical Investigation. 127(11). 4001–4017. 27 indexed citations
19.
Palaskar, Sangeeta, et al.. (2010). Low-Grade Spindle-Cell Ameloblastic Carcinoma: Report of an Unusual Case with Immunohistochemical Findings and Review of the Literature. Current Oncology. 17(5). 52–57. 20 indexed citations
20.
Kaur, Harsimar, et al.. (1977). Squamous cell carcinoma of the larynx with sarcoma like stroma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 32(2). 172–4. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026